ClinVar Miner

Submissions for variant NM_000492.4(CFTR):c.3731G>A (p.Gly1244Glu) (rs267606723)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
CFTR2 RCV000056386 SCV000071499 pathogenic Cystic fibrosis 2017-03-17 reviewed by expert panel research
PharmGKB RCV000211150 SCV000268279 drug response ivacaftor response - Efficacy 2018-03-23 reviewed by expert panel curation PharmGKB Level of Evidence 1A: Annotation for a variant-drug combination in a CPIC or medical society-endorsed PGx guideline, or implemented at a PGRN site or in another major health system.
Integrated Genetics/Laboratory Corporation of America RCV000056386 SCV000696985 pathogenic Cystic fibrosis 2016-03-31 criteria provided, single submitter clinical testing Variant summary: The CFTR c.3731G>A variant affects a conserved nucleotide, resulting in amino acid change from Gly to Glu. 5/5 in-silico tools predict a damaging outcome for this variant, and G1244E has been shown to drastically reduce chloride channel activity and HCO3- transport by in vitro studies (Anderson et al 1992, Choi et al 2001, Yu et al 2012, and Sosnay et al 2013). This variant was found in 2/121206 control chromosomes at a frequency of 0.0000165, which does not exceed maximal expected frequency of a pathogenic CFTR allele (0.0129603). In addition, the CFTR2 database and several independent publications consider the variant pathogenic/CF-causing. Taken together, this variant was classified as pathogenic.
Fulgent Genetics,Fulgent Genetics RCV000763160 SCV000893747 pathogenic Bronchiectasis with or without elevated sweat chloride 1; Cystic fibrosis; Hereditary pancreatitis; Congenital bilateral aplasia of vas deferens from CFTR mutation 2018-10-31 criteria provided, single submitter clinical testing
Baylor Genetics RCV001004504 SCV001163549 pathogenic Cystic fibrosis; Congenital bilateral aplasia of vas deferens from CFTR mutation criteria provided, single submitter clinical testing
CFTR-France RCV000056386 SCV001169361 pathogenic Cystic fibrosis 2018-01-29 criteria provided, single submitter curation
Counsyl RCV000056386 SCV001132353 pathogenic Cystic fibrosis 2015-03-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.